Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Drug Dev Res ; 84(7): 1376-1394, 2023 11.
Artículo en Inglés | MEDLINE | ID: mdl-37534768

RESUMEN

Catalpol is a kind of iridoid glucoside, widely found in a variety of plants, mostly extracted from the rhizome of the traditional medicinal herb rehmanniae. It has various biological activities such as anti-inflammatory, antioxidant, and antitumor. The anti-inflammatory effects of catalpol have been demonstrated in a variety of diseases, such as neurological diseases, atherosclerosis, renal diseases, respiratory diseases, digestive diseases, bone and joint diseases, eye diseases, and periodontitis. The purpose of this review is to summarize the existing literature on the anti-inflammatory effects of catalpol in a variety of inflammatory diseases over the last decade and to focus on the anti-inflammatory mechanisms of catalpol.


Asunto(s)
Antiinflamatorios , Glucósidos Iridoides , Glucósidos Iridoides/farmacología , Glucósidos Iridoides/uso terapéutico , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico
2.
Molecules ; 28(13)2023 Jun 25.
Artículo en Inglés | MEDLINE | ID: mdl-37446647

RESUMEN

Acute pancreatitis (AP) is a digestive emergency and can develop into a systematic illness. The role of the gut in the progression and deterioration of AP has drawn much attention from researchers, and areas of interest include dysbiosis of the intestinal flora, weakened intestinal barrier function, and bacterial and endotoxin translocation. Short-chain fatty acids (SCFAs), as one of the metabolites of gut microbiota, have been proven to be depleted in AP patients. SCFAs help restore gut homeostasis by rebuilding gut flora, stabilizing the intestinal epithelial barrier, and regulating inflammation. SCFAs can also suppress systematic inflammatory responses, improve the injured pancreas, and prevent and protect other organ dysfunctions. Based on multiple beneficial effects, increasing SCFAs is an essential idea of gut protective treatment in AP. Specific strategies include the direct use of butyrate or indirect supplementation through fiber, pre/pro/synbiotics, or fecal microbiota transplantation as a promising adjective therapy to enteral nutrition.


Asunto(s)
Pancreatitis , Humanos , Pancreatitis/terapia , Enfermedad Aguda , Ácidos Grasos Volátiles/metabolismo , Butiratos , Inflamación/metabolismo
3.
Theranostics ; 13(8): 2616-2631, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37215575

RESUMEN

Alternative splicing (AS) is a common and conserved process in eukaryotic gene regulation. It occurs in approximately 95% of multi-exon genes, greatly enriching the complexity and diversity of mRNAs and proteins. Recent studies have found that in addition to coding RNAs, non-coding RNAs (ncRNAs) are also inextricably linked with AS. Multiple different types of ncRNAs are generated by AS of precursor long non-coding (pre-lncRNAs) or precursor messenger RNAs (pre-mRNAs). Furthermore, ncRNAs, as a novel class of regulators, can participate in AS regulation by interacting with the cis-acting elements or trans-acting factors. Several studies have implicated abnormal expression of ncRNAs and ncRNA-related AS events in the initiation, progression, and therapy resistance in various types of cancers. Therefore, owing to their roles in mediating drug resistance, ncRNAs, AS-related factors and AS-related novel antigens may serve as promising therapeutic targets in cancer treatment. In this review, we summarize the interaction between ncRNAs and AS processes, emphasizing their great influences on cancer, especially on chemoresistance, and highlighting their potential values in clinical treatment.


Asunto(s)
Neoplasias , ARN Largo no Codificante , Humanos , Empalme Alternativo/genética , ARN no Traducido/genética , ARN no Traducido/metabolismo , ARN Largo no Codificante/genética , ARN Largo no Codificante/metabolismo , Neoplasias/tratamiento farmacológico , Neoplasias/genética
4.
Bioresour Technol ; 370: 128581, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36608857

RESUMEN

The potential of palm oil and derived wastewater pretreated by enzyme as co-substrates to accumulate polyhydroxyalkanoate (PHA) rich in short and medium-chain-length monomers under two feeding strategies was evaluated batchwise through mixed microbial cultures (MMCs) in activated sludge. A terpolymer with the maximum PHA content of 30.5 wt%, volumetric yield of 0.372 g COD/g COD and composition of ca. 84.7 âˆ¼ 97.4/0.5 âˆ¼ 1.6/2.1 âˆ¼ 13.7 (3-hydroxybutyrate/ 3-hydroxyvalerate/ 3-hydroxyoctanoate, %) was achieved as a result of co-substrate incorporation. From the perspective of economic benefits, PHA accumulated via adopting strategy of supplementing carbon source to the same initial concentration per cycle saved 42.7 % of carbon consumption, along with a reduction in culture time (72 h). The above discoveries signify that the combination of palm oil and derived wastewater plus MMCs provides an alternative to the plastics industries for a more sustainable and efficient utilization of biological resources and an economic PHA accumulation approach.


Asunto(s)
Polihidroxialcanoatos , Aguas Residuales , Aguas del Alcantarillado , Polihidroxialcanoatos/metabolismo , Aceite de Palma , Reactores Biológicos
5.
Front Pharmacol ; 13: 1050224, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36523494

RESUMEN

Acute lung injury (ALI) is an inflammatory response which causes serious damages to alveolar epithelia and vasculature, and it still remains high lethality and mortality with no effective treatment. Based on the inflammatory homing of platelets and cell membrane cloaking nanotechnology, in this study we developed a biomimetic anti-inflammation nanoparticle delivery system for ALI treatment. PM@Cur-RV NPs were designed by combining the poly (lactic-co-glycolic acid) nanoparticles (NPs) coated with platelet membrane vesicles (PM) for the purpose of highly targeting delivery of curcumin (Cur) and resveratrol (RV) to inflammatory lungs. PM@Cur-RV NPs showed good biocompatibility and biosafety both in vitro and in vivo. Accumulation of NPs into lung tract was observed after inhaled NPs. Remarkably, the inhalation of PM@Cur-RV NPs effectively inhibited lung vascular injury evidenced by the decreased lung vascular permeability, and the reduced proinflammatory cytokine burden in an ALI mouse model. The analysis of infiltrated macrophages in the lungs showed that the Cur-RV-modulated macrophage polarized towards M2 phenotype and the decreased histone lactylation might contribute to their anti-inflammation effects. Together, this work highlights the potential of inhalation of biomimetic nanoparticle delivery of curcumin and resveratrol for the treatment of pulmonary diseases.

6.
Sci Rep ; 11(1): 16307, 2021 08 11.
Artículo en Inglés | MEDLINE | ID: mdl-34381116

RESUMEN

Structure-based drug design targeting the SARS-CoV-2 virus has been greatly facilitated by available virus-related protein structures. However, there is an urgent need for effective, safe small-molecule drugs to control the spread of the virus and variants. While many efforts are devoted to searching for compounds that selectively target individual proteins, we investigated the potential interactions between eight proteins related to SARS-CoV-2 and more than 600 compounds from a traditional Chinese medicine which has proven effective at treating the viral infection. Our original ensemble docking and cooperative docking approaches, followed by a total of over 16-micorsecond molecular simulations, have identified at least 9 compounds that may generally bind to key SARS-CoV-2 proteins. Further, we found evidence that some of these compounds can simultaneously bind to the same target, potentially leading to cooperative inhibition to SARS-CoV-2 proteins like the Spike protein and the RNA-dependent RNA polymerase. These results not only present a useful computational methodology to systematically assess the anti-viral potential of small molecules, but also point out a new avenue to seek cooperative compounds toward cocktail therapeutics to target more SARS-CoV-2-related proteins.


Asunto(s)
Antivirales/farmacología , Evaluación Preclínica de Medicamentos , Medicamentos Herbarios Chinos/farmacología , Medicina Tradicional China , SARS-CoV-2/efectos de los fármacos , Proteínas Virales/metabolismo , Enzima Convertidora de Angiotensina 2/metabolismo , Animales , Antivirales/química , Antivirales/metabolismo , Gatos , Biología Computacional , Medicamentos Herbarios Chinos/química , Medicamentos Herbarios Chinos/metabolismo , Flavonoides/metabolismo , Humanos , Simulación de Dinámica Molecular , Unión Proteica , ARN Polimerasa Dependiente del ARN/metabolismo , Glicoproteína de la Espiga del Coronavirus/metabolismo , Relación Estructura-Actividad
7.
Talanta ; 211: 120660, 2020 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-32070626

RESUMEN

An electrochemiluminescence and photothermal immunosensor based on a dual-modality integrated probe was proposed for sensitive and reliable detection of lipolysis stimulated lipoprotein receptor (LSR), a new biomarker of ovarian cancer. Black phosphorous quantum dots (BPQDs) possess fascinating electrochemical property and unique photothermal effect, which could not only enhance ECL signal of N-(4-aminobutyl)-N-ethylisoluminol (ABEI) through accelerating dissolved O2 evolution but also realize temperature signal output by converting laser energy into heat. Furthermore, NiFe2O4 nanotubes (NiFe2O4 NTs) have large specific surface area and favorable adsorption ability, which could increase the immobilized amount of ABEI and BPQDs, further strengthening ECL and temperature signal. As a result, a dual-mode immunosensor was constructed and realized ECL and temperature dual signal to detect LSR, making the results more reliable. This work provided a new thought for the development of sensitive and accurate sensors and was expected to employ for determination of other biomarkers.


Asunto(s)
Biomarcadores de Tumor/análisis , Técnicas Biosensibles , Compuestos Férricos/química , Nanotubos/química , Níquel/química , Neoplasias Ováricas , Fósforo/química , Puntos Cuánticos/química , Receptores de Lipoproteína/análisis , Anticuerpos/química , Biomarcadores de Tumor/inmunología , Técnicas Electroquímicas , Femenino , Humanos , Inmunoensayo , Luz , Mediciones Luminiscentes , Luminol/análogos & derivados , Luminol/química , Receptores de Lipoproteína/inmunología , Temperatura
8.
Zhongguo Zhen Jiu ; 40(1): 54-7, 2020 Jan 12.
Artículo en Chino | MEDLINE | ID: mdl-31930900

RESUMEN

The value of the "touching-bone" acupuncture technique in clinical application was explained through the investigation on the origin of the theory of the "touching-bone" acupuncture technique, the analysis on the characteristics of acupoint selection, the introduction of clinical characteristics and the discussion on the mechanism of acupuncture in treatment. The "touching-bone" acupuncture technique refers to deep needling method, originated from the short needling and shu needling of the ancient needling methodslisted in the Internal Classic. The target points are the reaction sites on meridian near to bone and the attachments of soft tissues on bone. During the needle insertion, the needle tip is thrust deeply to the bone or the needle body is closely attached to the bone so as to stimulate periosteum specifically. This needling technique contributes to the satisfactory effect on spasmodic, deep-located and intractable pain disorder, motor system diseases, mental diseases and cerebral diseases, etc. Hence, this acupuncture technique deserves to be promoted in clinical application and explored in research.


Asunto(s)
Terapia por Acupuntura , Meridianos , Agujas
9.
J Clin Endocrinol Metab ; 98(4): 1353-60, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23436920

RESUMEN

CONTEXT: There is uncertainty over the dose of (131)I required for thyroid remnant ablation. Most previous studies have been inadequately powered to establish the best fixed dose of (131)I for effective ablation. OBJECTIVE: The aim of the study was to assess the effects of low- vs high-dose regimens of radioiodine in thyroid remnant ablation for patients with differentiated thyroid carcinoma. DATA SOURCES: Sources included the Cochrane Library, MEDLINE, EMBASE, and SCOPUS (all until September 2012). STUDY SELECTION: Randomized controlled trials that assess the efficacy of low- or high-dose of radioiodine ablation of thyroid remnants were collected. DATA EXTRACTION: Two authors performed the data extraction independently. DATA SYNTHESIS: Nine randomized controlled trials involving 2569 patients were included. The 1100-MBq vs the 3700-MBq radioiodine showed no statistically significant difference in successful thyroid remnant ablation (risk ratio [RR], 0.91 [0.79 to 1.04]; P = .15), both the 1100 vs the 1850 MBq (RR, 0.95 [0.83 to 1.10]; P = .52) and the 1850 vs the 3700 MBq (RR, 1.00 [0.85 to 1.17]; P = .98) also showed no significant differences (95% confidence intervals were calculated for each estimate). Also, no significant differences existed in quality-of-life scores on the SF-36 between different (131)I-dose groups both on the day of ablation (RR, 0.15 [-0.65 to 0.96], P = .71; I(2) = 29%, P = .24) and 3 months after ablation (RR, -1.1 [-2.37 to 0.17], P = .09; I(2) = 22%, P = .26). A low dose of 1100 MBq radioiodine showed significant benefits in reducing adverse effects (total RR, 0.65 [0.55 to 0.77], P < .1; I(2) = 31%, P =.14) and shorter hospital isolation (RR, 0.4 [0.32 to 0.50]; P < .05). CONCLUSIONS: The low dose of 1100 MBq radioiodine activity is sufficient for thyroid remnant ablation as compared to 3700 MBq radioiodine activity with similar quality of life, less common adverse effects, and a shorter hospital stay.


Asunto(s)
Carcinoma/radioterapia , Radioisótopos de Yodo/administración & dosificación , Neoplasias de la Tiroides/radioterapia , Adolescente , Adulto , Carcinoma/patología , Carcinoma/cirugía , Diferenciación Celular , Relación Dosis-Respuesta en la Radiación , Humanos , Radioisótopos de Yodo/efectos adversos , Neoplasia Residual , Calidad de Vida , Dosificación Radioterapéutica , Radioterapia Adyuvante , Ensayos Clínicos Controlados Aleatorios como Asunto/estadística & datos numéricos , Neoplasias de la Tiroides/patología , Neoplasias de la Tiroides/cirugía , Tiroidectomía , Resultado del Tratamiento , Adulto Joven
10.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 27(11): 1016-9, 2007 Nov.
Artículo en Chino | MEDLINE | ID: mdl-18173151

RESUMEN

OBJECTIVE: To observe the effects of tetrandrine (Tet) on the pulmonary capillary permeability in rats with acute lung injury induced by intravenous injection of lipopolysaccharide (LPS). METHODS: Thirty-two healthy male Wistar rats were randomly divided into 4 groups: the model group, the normal group, the Tet prevention group and the Tet treatment group, 8 in each group. All rats except those in the normal group, were established into acute lung injury model by intravenous injection of LPS. Intravenous injection of Tet (20 mg/ kg) were given to the Tet prevention group 30 min before and to the Tet treatment group 30 min after modeling respectively, and equal volume of normal saline was given to the other two groups instead. Arterial blood samples were collected to determine PaO2 and PaCO2 at the time points of immediately after modeling (0 h), 0.5 h, 2 h, 4 h, 6 h. The animals were sacrificed by the end of the experiment, the wet/dry weight ratio of lung (W/ D), neutrophil percentage in bronchoalveolar lavage fluid (BALF), concentration of TNF-a in peripheral blood and BALF by ELISA, and content of malonaldehyde (MDA) in lobus inferior pulmonis homogenate by thio barbituric acid colorimetric method were determined. Pathological change of the upper lobe of lung was examined and lung injury was scored as well. RESULTS: As compared with that in the model group, the level of PaO2 was higher in Tet prevention group at 0.5 h, 2 h, 4 h, 6 h and in the Tet treatment group at 2 h, 4 h, 6 h (P< 0.05); and the content of TNF-alpha, MDA and neutrophil percentage in BALF, as well as W/D and lung injury score were lower in the Tet prevention group and the Tet treatment group (P <0.05). Pathological changes of lung in the two Tet groups were all better than those in the model group. CONCLUSION: Early intervention with tetrandrine shows a protectiv effect on rats against acute lung injury induced by intravenous injection of LPS.


Asunto(s)
Lesión Pulmonar Aguda/fisiopatología , Bencilisoquinolinas/farmacología , Permeabilidad Capilar/efectos de los fármacos , Pulmón/irrigación sanguínea , Lesión Pulmonar Aguda/inducido químicamente , Lesión Pulmonar Aguda/patología , Animales , Medicamentos Herbarios Chinos/farmacología , Femenino , Lipopolisacáridos , Masculino , Distribución Aleatoria , Ratas , Ratas Wistar
11.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 26(11): 1015-7, 1020, 2006 Nov.
Artículo en Chino | MEDLINE | ID: mdl-17186734

RESUMEN

OBJECTIVE: To study the suppressive role of emodin on the growth and its effect on the proliferation cycle and apoptotic gene of human lung adenocarcinoma cell line Anip 973. METHODS: The survival rate and the inhibitory rate of Anip 973 cell in vitro were detected by MTT colorimetric assay and cell growth curve assay at different time points under different concentration of emodin; the cell proliferation cycle and the apoptotic rate were examined with flow cytometry analysis, and Caspase-3 protein expression was measured by immunoblotting assay. RESULTS: Emodin inhibited the proliferation of Anip 973 cell at G0/G1 phase, decreased the cell ratio at S phase and activated the Caspase-3 protein. It suppressed the growth of tumor cells and raised the apoptotic rate in a concentration and time depending manner in a certain extent. CONCLUSION: Emodin could suppress the proliferation of Anip 973 cell, and its mechanism of anticancer effect may be through activating Caspase-3, to induce apoptosis and block cell cycle.


Asunto(s)
Apoptosis/efectos de los fármacos , Caspasa 3/metabolismo , Proliferación Celular/efectos de los fármacos , Emodina/farmacología , Adenocarcinoma/metabolismo , Adenocarcinoma/patología , Anciano , Antineoplásicos Fitogénicos/farmacología , Western Blotting , Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Relación Dosis-Respuesta a Droga , Humanos , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/patología , Masculino
12.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 25(7): 640-2, 2005 Jul.
Artículo en Chino | MEDLINE | ID: mdl-16089145

RESUMEN

OBJECTIVE: To investigate the anti-tumor mechanisms of emodin on human lung adenocarcinoma cell line Anip973 (LACC). METHODS: The influence of emodin of different concentration at different time on LACC proliferation were determined and compared using MTT colorimeric assay and cell growth curve assay. And the cell apoptotic rate was determined by flow cytometry and analyzed with electronic microscope. RESULTS: In a certain range, the higher concentration and longer acting time of emodin could induce the stronger inhibitory effect on tumor cell growth and the higher apoptotic rate. The proliferation inhibitory rate reached 90% after LACC being treated with emodin 60 micromol/L for 72h. CONCLUSION: Emodin can significantly inhibit proliferation of human LACC, showing dose-effect and time-effect relationship.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Apoptosis/efectos de los fármacos , Emodina/farmacología , Neoplasias Pulmonares/patología , Adenocarcinoma/patología , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA